Chromatography Resin Market Research Report Information By Type (Natural Resin, Synthetic Resin, Inorganic Media) Technique (Ion-exchange chromatography, Affinity chromatography, Hydrophobic interaction chromatography, Size exclusion chromatography, Multi-modal chromatography, Others) Forecast 2032

Global Chromatography Resin Market Overview

The Chromatography Resins Market Size was valued at USD 14594.77 Million in 2023. The chromatography resins industry is projected to grow from USD 15601.81 Million in 2024 to USD 26607.04 Million by 2032, exhibiting a compound annual growth rate (CAGR) of 6.90% during the forecast period (2024 - 2032).

Chromatography is a process to split or separate a blend of colored components into individual elements. Chromatography resins help in the isolation of desired components from a mixture of compounds. They are incorporated into chromatography devices and are used in diagnostic test development and separation of biomolecules. Choice of resins is very crucial to ensure an effective and accurate separation of individual components.

Chromatography resins are media used to capture and polish mAbs, antibody fragments, vaccines, and other biomolecules using a stationary phase. There are multiple types of ion-exchange resin. Most commercial resins are made of polystyrene sulfonate.

COVID-19 Impact on the Chromatography Resin Market

The outbreak of COVID-19 has had a positive impact on the global chromatography resin market. This is attributed to the development of effective vaccines and treatments by companies and governments worldwide, which resulted in the employment of robust analytical methods by researchers across the globe.

Researchers used chromatography, a strong laboratory-based analytical approach, to better understand the Sars-CoV-2 virus and develop new medicines, vaccines, and diagnostic tools to aid in the fight against the Covid-19 epidemic. Because of its central role in viral pathogenesis, the SARS-CoV-2 virus's spike protein has piqued researchers' interest as a vaccine target. While many researchers have attempted to classify the spike protein's glycopeptides and glycans, intact protein analysis utilizing reversed-phase liquid chromatography (RPLC) may provide novel analytical insights. More effective medicines can be identified and developed by refining functional and structural understanding of the intact spike protein. Liquid chromatography coupled with mass spectrometry was used to quantify remdesivir in the blood plasma of a COVID-19 patient and thus provide data on its efficacy as a treatment for SARS-CoV-2.

The crucial need for developing the effective treatment for COVID-19 during the year 2020 resulted in high demand for chromatographic techniques, thus, having a positive impact on the global market.

Market Dynamics

Drivers

• Use of chromatography techniques in pharmaceuticals & biotechnology industry: The HPLC chromatography technique is considered the most important analytical technique used in the pharmaceutical business to identify and quantify pharmaceuticals. This is used either in the active pharmaceutical ingredient or in the formulations during the research, development, and production of a medicine. The chromatography methods are accurate, precise, quick, specific, and easy; therefore, they are widely used for regular quality control examination of medicines in bulk and pharmaceutical dosage form. They can be used in drug research and development, drug impurity analysis, assay, content uniformity, and drug method development and validation. HPLC's capacity to reveal the structure and determine the amounts of contaminants in pharmaceutical formulations is one of its key advantages. HPLC is particularly well suited to chemicals that are difficult to volatilize, are thermally unstable, and have large molecular weights. As a result, it can measure a medication in both its pure and dose form.

Restraints

• High cost of affinity resins: In a typical platform process for the manufacturing of mAb therapies, the steps following fermentation account for over 80% of the total process costs, with chromatography accounting for up to 60% of the downstream expenses. Protein A resin is the most significant contributor to the entire cost. Traditional chromatographic medium with non-proteinaceous ligands cost roughly half as much as Protein A resin. The cost of resin for a large column (diameter >1 m) can surpass USD 1 million. The fact that most antibody therapies require frequent and substantial doses of Protein A makes the expense of Protein A resin even more difficult.

Opportunity

• Increasing demand for biosimilars: Each biosimilar is made using the same amino acid starting materials and the same precise, step-by-step processes as its reference drug — a well-tested, widely-used biologic drug that’s already been on the market for years. All biosimilars are prescription drugs. Biosimilars are intended to provide a more cost-effective alternative to high-priced branded biologics. This will help in easy accessibility of medicines and appropriate therapies for the patients.

Trends

• Adoption of green chromatography: To lessen the risks to the environment and human health associated with the use of chromatography, scientists have modified the technology such that non-toxic chemicals can be used instead of toxic ones where possible, and the energy consumption is lowered and derived from renewable sources. Acetonitrile, a volatile organic molecule, is the most widely used solvent in chromatography. According to studies, a mixture of propylene carbonate–ethanol–water can be used to substitute this harmful solvent with equivalent efficacy. Other research has indicated that a mixture of ethyl acetate and ethanol can be utilized as a more environmentally acceptable alternative to acetonitrile. Solutions of 0.04% triethylamine in water are also an effective alternative for toxic chemicals used in chromatography

Segmentation

By Type

• Natural Resin


• Synthetic Resin


• Inorganic Media

By Technique

• Ion-exchange chromatography


• Affinity chromatography


• Hydrophobic interaction chromatography


• Size exclusion chromatography


• Multi-modal chromatography


• Others

By Application

• Pharmaceuticals & biotechnology


• Food & beverages


• Water & environment analysis


• Academics & research


• Others

By Region

• North America


• Europe


• Asia-Pacific


• Latin America


• Middle East & Africa

Regional Analysis

The Global Chromatography resin Market has been studied across five regions: North America, Asia-Pacific, Europe, Latin America, and the Middle East & Africa. North America accounted for a largest market share in 2021. The North American market has been divided into the US and Canada. The US was the largest pharmaceutical market in 2021, generating about USD 12,771.5 million representing around 40% of the global revenue generated worldwide. According to AstraZeneca, North America is expected to continue to lead global pharmaceutical sales in the year 2022 with USD 13,279.8 million.

Asia-Pacific accounted for 21.30% of the global market share in 2021 and is expected to reach a value of USD 22,750.0 million by the end of the forecast period. The growth of the region can be associated with the growth of the pharmaceutical industry in China, India, and Japan.

China has solidified its position as a key player in the global pharmaceutical sector, both as a consumer and as a base for expanding R&D. Domestic and global pharmaceutical companies are expanding and introducing new products in China, which is a key factor for the growth of the chromatography resin market.

Competitive Landscape

Chromatography resin market is expected to register healthy growth throughout the forecast period. The market represents strong numbers in terms of consumption and is expected to grow year on year. Chromatography resin market is highly fragmented, with presence of numerous tier-1, tier-2, and unorganized players.

Some of the key players operating in chromatography resin market Tosoh Corporation (Japan), Thermo Fisher Scientific Inc (US), Repligen Corporation (US), Avantor Performance Materials Inc (US), Merck KGaA (Germany), Bio-Rad Laboratories Inc (US), Pall Corporation (US), Mitsubishi Chemical Corporation (Japan), GE Healthcare (US), R.Grace & Co (US) and Purolite Corporation (US).

Report Overview:

The Chromatography resin market is segmented by Type, Technique, application, and region in the report. In terms of insights, this report has focused on various levels of analysis such as market dynamics, value chain analysis, Porter's five forces, competitive landscape, and company profiles—all of which comprise and discuss views on the global chromatography resin emerging and fast-growing segments, regions, and countries.

Objectives of the Study

• To get a comprehensive overview of the global chromatography resin market


• To get wide-ranging information about the key factors driving the market and market opportunities


• To gain information regarding the key players in the industry, their product portfolio, strategies, and key developments


• To gain insights about the key country/region in which the market is growing

Intended Audience

• Industrial sector


• Academics


• Pharmaceutical industries


• Agrochemical industries

Report Attribute/Metric	Details
Market Size 2023	USD  14594.77 Million
Market Size 2024	USD 15601.81 Million
Market Size 2032	USD 26607.04 Million
Compound Annual Growth Rate (CAGR)	6.90% (2024-2032)
Base Year	2023
Market Forecast Period	2024-2032
Historical Data	2018 & 2020
Market Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered	Application, End-Use Industry
Geographies Covered	North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered	The U.S, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled	Tosoh Corporation (Japan), Thermo Fisher Scientific Inc (US), Repligen Corporation (US), Avantor Performance Materials Inc (US), Merck KGaA (Germany), Bio-Rad Laboratories Inc (US), Pall Corporation (US), Mitsubishi Chemical Corporation (Japan), GE Healthcare (US), R.Grace & Co (US) and Purolite Corporation (US).
Key Market Opportunities	Use of chromatography techniques in pharmaceuticals & biotechnology industry
Key Market Dynamics	Increasing demand for biosimilars